• Mnemosyne Pharmaceuticals Inc., of Providence, R.I., increased its Series A financing with the addition of a new $6 million expansion round. The expansion round includes one new investor, Atlas Venture, and one existing investor, Clal Biotechnology Industries (CBI, previously Access Bridgegap Ventures). Peter Barrett, partner at Atlas, will join Mnemosyne's board, along with William Koster for CBI.